¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"contralateral antagonist"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral antagonist
¹Ý´ëÂÊ´ëÇ×±Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral
¹Ý´ëÂÊ-, ¸ÂÀºÆí-
contralateral hemiplegia
¹Ý´ëÂʹݽŸ¶ºñ
contralateral sign
´ëÃøÂ¡ÈÄ, ¹Ý´ëÂÊ¡ÈÄ
antagonist
1. ´ëÇ×Á¦, ±æÇ×Á¦ 2. ´ëÇ×±Ù
adrenergic antagonist
¾Æµå·¹³¯¸°´ëÇ×Á¦, ¾Æµå·¹³¯¸°±æÇ×Á¦
competitive antagonist
°æÀï´ëÇ×Á¦
direct antagonist
Á÷Á¢´ëÇ×±Ù
dopaminergic antagonist
µµÆÄ¹Î´ëÇ×Á¦, µµÆÄ¹Î±æÇ×Á¦
muscarinic antagonist
¹«½ºÄ«¸°´ëÇ×Á¦
narcotic antagonist
¸¶¾à´ëÇ×Á¦
neuromuscular antagonist
½Å°æ±Ù(À°)´ëÇ×Á¦
opioid antagonist
¾ÆÆíÀ¯»çÁ¦´ëÇ×Á¦
specific antagonist
ƯÀÌ´ëÇ×Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antagonist
1.´ëÇ×Á¦, ±æÇ×Á¦, 2.´ëÇ×±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral antagonist
¹Ý´ëÂÊ´ëÇ×±Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral
¹Ý´ëÂÊ-, ¸ÂÀºÆí-
contralateral hemiplegia
¹Ý´ëÂʹݸ¶ºñ
contralateral reflex
¹Ý´ëÂʹݻç
contralateral sign
¹Ý´ëÃø¼ºÂ¡ÈÄ, ¹Ý´ëÂÊ´Ù¸®Â¡ÈÄ
antagonist
´ëÇ×Á¦, ¸Â¹öÆÀÁ¦
adrenergic antagonist
¾Æµå·¹³¯¸°´ëÇ×Á¦
competitive antagonist
°æÀï´ëÇ×¹°Áú
direct antagonist
Á÷Á¢´ëÇ×±Ù
dopaminergic antagonist
µµÆÄ¹Î´ëÇ×Á¦, µµÆÄ¹Î¸Â¹öÆÀÁ¦
ipsilateral antagonist
°°ÀºÂÊ´ëÇ×±Ù
muscarinic antagonist
¹«½ºÄ«¸°´ëÇ×Á¦
narcotic antagonist
¸¶¾à´ëÇ×Á¦
neuromuscular antagonist
½Å°æ±ÙÀ°´ëÇ×Á¦
opioid antagonist
¾ÆÆíÀ¯»ç¹°Áú´ëÇ×Á¦
specific antagonist
ƯÀÌ´ëÇ×Á¦
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
9
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
H2 receptor antagonist
H2 ¼ö¿ëü ±æÇ×Á¦µé
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
androgen antagonist
³²¼ºÈ£¸£¸ó ±æÇ×Á¦
antagonist
±æÇ×Á¦
antagonist
±æÇ×Á¦(ÑÏù÷ð¥)
antagonist
±æÇ×Á¦, ±æÇ×¹°Áú, ±æÇ×±Ù, ±æÇ×¾à.
heavy metal antagonist
Á߱ݼӱæÇ×¾à(̡˻ËÛ˻̰Ëâ).
heavy metal antagonist
Á߱ݼӱæÇ×¾à(ñìÐÝáÕÑÏù÷å·).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral antagonist
¹Ý´ëÃø±æÇ×±Ù
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
contralateral
´ëÃøÀÇ, Å¸Ãø¼º, ¹Ý´ëÃø, ±³Â÷ÀûÀÎ.
contralateral reflex
(¹Ý)´ëÃø¼º(Óßö°àõÚãÞÒ).
contralateral sign
(¹Ý)´ëÃø¼º ¡ÈÄ(¡ó£ý¦).
contralateral synergist
¹Ý´ëÃøÇùµ¿±Ù, ¹Ý´ëÃø°øµ¿±Ù
adrenergic antagonist
¾Æµå·¹³¯¸° ±æÇ×¹°Áú
adrenergic antagonist
¾Æµå·¹³¯¸°¼º ±æÇ×Á¦
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
androgen antagonist
³²¼ºÈ£¸£¸ó ±æÇ×Á¦
antagonist
±æÇ×Á¦(ÑÏù÷ð¥)
antagonist
±æÇ×Á¦, ±æÇ×¹°Áú, ±æÇ×±Ù, ±æÇ×¾à.
antagonist
±æÇ×Á¦
associated antagonist
°ø¾×±æÇ×¹°Áú.
benzodiazepine receptor antagonist(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ±æÇ×Á¦
beta-adrenergic antagonist
º£Å¸ ¾Æµå·¹³¯¸°¼º ÀúÇØÁ¦
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½